Abstract
Purpose: PSMA PET-CT has been shown to demonstrate superior diagnostic accuracy to choline PET-CT for metastatic disease [1,2] although clinical availability of these imaging techniques is heterogenous. We report on differences between these modalities, focusing on metastatic/recurrent disease detection rates and referrals for SABR in the context of oligometastatic disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have